Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03151798 · ClinicalTrials.gov registry record · NA
The Liver Health Study for Patients with NAFLD
A NA study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 336
- Enrollment target
NCT03151798: Completed NA study, sponsored by University of Missouri-Columbia.
NCT03151798 is a NA study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 336 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03151798, a NA study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 336 participants
- Enrollment target
Study Summary
The study will investigate whether the level of fat stored in the liver is related to the liver's ability to burn fat.
Primary Outcome
Liver tissue will be tested in vitro to determine the abundance of transcript indicative of fat oxidation.
Interventions
- BEHAVIORAL Phase II: Lifestyle treatment
- BEHAVIORAL Phase II: Control treatment
- OTHER Phase I: Observational studies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 336 participants |
| Start Date | 2017-08-09 |
| Est. Completion | 2023-04-29 |
| Phase | NA |
What the finished NCT03151798 record still lists
NCT03151798 is an interventional study that assigns participants to a tested intervention. The registered 336 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower).
The record links to 0 conditions, and to 3 interventions - of which Phase II: Lifestyle treatment is the first listed.
NCT03151798 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03151798 about?
NCT03151798 is a clinical study titled "The Liver Health Study for Patients with NAFLD". The study will investigate whether the level of fat stored in the liver is related to the liver's ability to burn fat.
What is the current status of trial NCT03151798?
This trial is currently completed. It is a NA study. The enrollment target is 336 participants. The study started on 2017-08-09. Estimated completion is 2023-04-29.
What interventions are being tested in trial NCT03151798?
The interventions under investigation include: Phase II: Lifestyle treatment (BEHAVIORAL), Phase II: Control treatment (BEHAVIORAL), Phase I: Observational studies (OTHER).
Who is sponsoring clinical trial NCT03151798?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03151798's enrollment target sits among peer trials
336 305th of 2000 higher than 1,696 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03947385 · 336 participants · Phase 1
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
- NCT03977207 · 336 participants · NA
A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients
- NCT04665206 · 336 participants · Phase 1
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
- NCT05124457 · 336 participants · Phase 2
DETERMINE: Detemir vs NPH
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI